Circular RNA circAGAP1 promotes sunitinib sensitivity in renal cell carcinoma via sponging multiple PDGFR-targeted miRNAs
Oncology Research · 2025
DOI: 10.32604/or.2024.047698 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology Research, 2025. Verfasst von Q I Lv und 10 weiteren Autor:innen. Beteiligte Einrichtung: Imaging Department, Tongji Hospital, Tongji University School of Medicine, Shanghai, 200065, China. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Sunitinib, MicroRNAs, RNA, Circular. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Imaging Department, Tongji Hospital, Tongji University School of Medicine, Shanghai, 200065, China.
- Urology Department, Huashan Hospital, Fudan University, Shanghai, 200040, China.
- Orthopedic Department, Shanghai General Hospital of Shanghai Jiaotong University, Shanghai, 200080, China.
Zitieren
APA
Lv, Q. I., Wang, G., Hong, Y. I., Zhu, T., Qin, S., Sun, S., Wang, Y., Liu, Y., Zhang, Q., Ma, C., & Wang, P. (2025). Circular RNA circAGAP1 promotes sunitinib sensitivity in renal cell carcinoma via sponging multiple PDGFR-targeted miRNAs. Oncology Research. https://doi.org/10.32604/or.2024.047698
Vancouver
Lv QI, Wang G, Hong YI, Zhu T, Qin S, Sun S, et al. Circular RNA circAGAP1 promotes sunitinib sensitivity in renal cell carcinoma via sponging multiple PDGFR-targeted miRNAs. Oncology Research. 2025. doi:10.32604/or.2024.047698
BibTeX
@article{Lv2025,
author = {Lv, Q I and Wang, Gangmin and Hong, Y I and Zhu, Tianyi and Qin, Shuang and Sun, Saifei and Wang, Yuting and Liu, Yaohua and Zhang, Qing and Ma, Chunhui and Wang, Peijun},
title = {Circular RNA circAGAP1 promotes sunitinib sensitivity in renal cell carcinoma via sponging multiple PDGFR-targeted miRNAs},
journal = {Oncology Research},
year = {2025},
doi = {10.32604/or.2024.047698}
}
EUVIMED